Objective Nocturia is a common reason for interrupted sleep in post-stroke patients. These patients often have neurogenic bladder overactivity. However, little is known about the possible contribution of nocturnal polyuria in the patients.
Introduction
A common reason for interrupted sleep in the general adult population is nocturia, which is waking during the night to urinate (1) . Nocturia may present solely but also with other lower urinary tract (LUT) symptoms, such as urinary urgency or urge urinary incontinence. Among the factors that predispose one to the development of the LUT symptoms are neurogenic bladder overactivity and nocturnal polyuria. As compared to bladder overactivity that commonly results from lesions in the mediofrontal cortex and the basal ganglia (2, 3) , nocturnal polyuria involves complexity of renal, cardiac and neural mechanisms (4, 5) . However, study of brain in neurological patients with nocturnal polyuria indicated that there is a lesion of the suprachiasmatic nucleus (SCN) (6) that regulates arginine vasopressin (AVP)-containing neurons in the paraventricular nucleus (PVN) and the supraoptic nucleus (SON), which lead to impaired circadian rhythm of plasma AVP concentration that normally rises in the night (7). The underlying conditions for nocturnal polyuria include degenerative neurological disorders such as multiple system atrophy (7-9) and Alzheimer's disease (10) , spinal cord injury (11, 12) , and aging (13) . However, little is known as to whether cerebrovascular diseases may cause nocturnal polyuria. Here, we describe our results of measurement of circadian plasma AVP level and urinary excretion in post-stroke patients. We also describe the effect of desmopressin (1-desamino-8-D-arginine vasopressin: DDAVP), a potent analogue of AVP (7), on nocturnal polyuria in a subset of the patients.
Methods
We recruited 4 post-stroke patients, all women, mean age 66 years, range 62-76 years ( Table 1 ). All patients were ambulant with or without an aid. The MRI and CT scans confirmed the location of lesions as multiple cerebral infarction in 2 with thalamo-hypothalamic lacunas, fronto-parietal infarction due to right middle cerebral artery occlusion in one, and left pontine infarction in one. None had apparent renal, ORIGINAL ARTICLE hepatic or cardiac diseases that might affect urinary secretion, and none was taking diuretic drugs. All patients had normal sleep-waking cycles. The study was made at least 4 weeks after an episode of stroke in each patient. First, urinary volume in the daytime (6 AM to 10 PM) and the nighttime (10 PM to 6 AM) was measured for 5 successive days, during which the number of nocturnal urination was counted. After these measurements, the average of each parameter was calculated. Nocturnal urinary frequency (nocturia) is defined as the number of urination during sleep in the nighttime as twice or more. Nocturnal polyuria is defined as the urinary output in the nighttime is more than 33% of total 24 hour volume (4). Secondly, the plasma AVP concentration was measured every 4 hours from 8 AM in the morning to 8 AM in the next morning, each measuring after 15 minutes' bed-rest, looking for a circadian rhythm of the plasma AVP level which normally rises in the nighttime, i.e., almost twofold as the baseline (14) . All patients gave informed consent before participating in the study.
Results
All patients had nocturnal urinary frequency (three times in one and twice in 3), which seemed to appear after the occurrence of stroke. In addition, all patients had nocturnal polyuria, and the ratio of nocturnal urinary output to 24 hour volume ranged from 36% to 63% (Fig. 1) . Measurement of the daily plasma AVP variation showed that all patients lost circadian rhythm of the plasma AVP concentration (Fig. 2) , which normally increased in the night. After the assessment, two of the patients (cases 3, 4) and their spouses requested to use 5 g of intranasal desmopressin once a night. We taught them how to use it and possible adverse events in detail, and observed them for 8 weeks during hospitalization and outpatient clinic, with regards to serum chemistry, electrolytes and cardiovascular function. During an observation period, the nocturnal polyuria successfully lessened in the patients (case 3: 36% to 25%, case 4: 51% to 38%). Both patients came to sleep better because of a reduction in the nocturia (case 3: twice to once, case 4: 3 times to once or twice) when on desmopressin. None of them showed hypertension particularly in the night, signs of congestive cardiac failure or any electrolyte abnormality such as hyponatremia.
Discussion
There is a circadian rhythm of urinary flow in normal children over 7 years and in adulthood (4) . The ratio of daytime to nighttime urine production is usually>2 : 1, so that 33% or less of daily urine output occurs during sleep. AVP, or antidiuretic hormone, is the major hormone responsible for the regulation of urine formation. In healthy adults, diurnal release of AVP into plasma has its peak during nighttime (14) . Loss of the AVP circadian rhythm occurs in congestive heart failure, nephrosis, and cirrhosis with ascites (14) . Central nervous system lesions affecting the hypothalamicposterior pituitary system also cause nocturnal polyuria [loss of AVP circadian rhythm due to the regulatory centre (SCN) lesion](6) and diabetes inspidus [loss of AVP secretion due to the secreting neuron (SON/PVN) lesion] (15). The present study revealed that all of our post-stroke patients lost circadian rhythm in the urinary excretion and in the AVP secretion into plasma. None of the patients had apparent renal, hepatic or cardiac diseases that might affect urinary output. The MRI and CT scans of the patients showed multiple cerebral infarction with thalamo-hypothalamic lacunas in 2. Other patients had no apparent lesion in the hypothalamus. However, the hypothalamic neurons have fibre connection with the frontal cortex and receive catecholaminergic projections from the pons and the medulla (16) , which are lesioned in the patients. These ischemic lesions, and neuronal degeneration by ageing as well (13) , may contribute to the loss of circadian rhythm in the AVP secretion in our post-stroke patients. However, in our patients, the impaired circadian rhythm was not so widespread since the sleep-waking cycle was maintained. Although the number of our patients was small, nocturnal polyuria most frequently resulted in nocturnal urinary frequency. It interrupts sleep of patients and their spouses, and may lead to accidental falls. Nocturnal polyuria also causes nocturnal dehydration, which may trigger a stroke recurrence in the patients. Desmopressin is a potent analogue of AVP (hypertensive and antidiuretic effects: 100, 100 in AVP; 0.39, 1,200 in desmopressin, respectively) (17) and widely used in the treatment of nocturnal enuresis in childhood (4) and nocturia of various aetiology (18, 19) . However, 20-40 g use of desmopressin may have adverse effects resulting from water retention and hyponatremia, particularly in the elderly patients (20, 21) . Therefore, we prescribed 5 g of intranasal desmopressin once a night in 2 patients with nocturnal polyuria. Although a small amount of each dose, desmopressin treatment improved the nocturnal polyuria in both patients together with an improvement of nocturnal urinary frequency. Both patients did not show hypertension, hyponatremia or other adverse effect during an observation period.
In conclusion, post-stroke patients may have a loss of circadian rhythm in AVP secretion and urinary excretion. Desmopressin successfully reduces nocturnal waking in urination. It also ameliorates nocturnal dehydration that might trigger a stroke recurrence in the patients.
